Omega-3 market is driven by factors such as rise in awareness among consumer about healthy & balanced diet and its health benefits. Moreover, omega-3 supplements such as eicosapentaenoic acid (EPA) and DHA reduces the risk of prostrate, colon, and breast cancer. An adequate amount of EPA decreases risk of depression and related health problems. The regulatory barrier limiting the consumption of omega-3 over certain range may restrain the market growth in the near future. Omega-3 obtained from plant origin, a good source of alpha-linolenic acid (ALA) for vegetarians, provides an opportunity for omega-3 market growth.
Download Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/1680
The omega-3 market is expected to reach $6,955 million by 2022, with a CAGR of 14.9% from 2016 to 2022.
Docosahexaenoic acid segment (DHA) dominated with three-fourths market share, in terms of revenue, in 2015. Dietary supplement application accounted for three-fifths of the global omega-3 market share, in terms of volume, in 2015 and is anticipated to grow at a CAGR of 14.1%.
The world ALA omega-3 market accounted for over $234 million in 2015. North America dominated the world ALA omega-3 market, in terms of revenue, generating $96 million in 2015. According to Eswara Prasad, Team Lead-Chemicals & Materials at Allied Market Research, “The global ALA market has great potential as compared to DHA and EPA as consumers constantly look for alternatives of fish oil”.
Omega-3 has a wide range of applications such as dietary supplement, pharmaceutical, infant formula, food & beverage, pet food, and fish feed. Dietary supplement is the major application and accounted for three-fifths of the global omega-3 market volume in 2015. Pharmaceutical is expected to grow (in terms of revenue) at CAGR of 18% from 2016 to 2022. The consumption of omega-3 (in terms of volume) in pharmaceutical and infant formula is estimated to increase at a higher CAGR of 18.8% and 16.3%, respectively, during the forecast period.
Fish and krill oils are two major marine sources for omega-3 fatty acid. Fish oil is applicable in aquaculture and nutraceuticals. Algal oil is one of the important sources of omega-3 fatty acid ingredients. Algal oil is the major alternative for production of omega-3; however, its relatively high price restricts its anticipated market penetration into the food and dietary supplement.
Buy This Report (263 Pages PDF with Insights, Charts, Tables, and Figures): https://www.alliedmarketresearch.com/checkout-final/e5004b498d8c0cf3903b053c4eec0ad9
The omega-3 market for infant formula witnesses’ high growth rate, in the packaged food category, due to developments in Asia (particularly China), East Europe markets, and in some parts of Middle East and Latin America. Increase in the global omega-3 production and rise in its demand are the major reasons for the higher growth rate in countries such as Mexico, The Netherlands, Poland, India, and Brazil.
The companies in this market adopt expansion and acquisition as their key strategies to develop distinguished products and reduce competition by capturing additional market share. The prominent players profiled in this report include Cargill, Incorporated, FMC Corporation, Croda International Plc, Royal DSM, OLVEA Fish Oils, Omega Protein Corporation, GC Rieber Oils, Luhua Biomarine (Shandong) Co., Ltd., Pharma Marine AS, and Polaris.
Key findings of the study:
- North America was the dominant region in 2015 both in terms of value & volume and is expected to continue this trend throughout the forecast period.
- Revenue generated by nuts & seeds is estimated to grow at a CAGR of 25.8%.
- Dietary supplement accounted for three-fifths of the global omega-3 demand in 2015.
- Fish & krill oil sources dominated, in terms of revenue, in 2015 and is projected to grow at a CAGR of 14.2%.
- DHA segment is expected to remain dominant throughout the period under consideration.
- U.S. contributed to one-third of the market revenue in 2015.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/1680